journal article·2017-04-03Open access

Development and characterization of embelin-loaded nanolipid carriers for brain targeting

Nancy Sharma, Saurav Bhandari, Rahul Deshmukh, Awesh K Yadav, Neeraj Mishra

Abstract

The objective of present work was to enquire the potential use of embelin-loaded nanolipid carriers for brain targeting. The average particle size and polydispersity index (PDI) of optimized formulation (F19) were found to be 152 ± 19.7 nm and 0.143 ± 0.023, respectively. Nanolipid carrier (NLC) was also significantly attenuated pentylenetetrazole (PTZ)-induced biochemical parameters in comparison to plain embelin that results in an increase in the level of malondialdehyde (MDA), nitrite, and reduction in the level of glutathione. From the results, it was concluded that embelin-NLCs developed as a beneficial carrier to achieve sustained release and brain targeting through nasal route.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Bioactive Compounds and Antitumor Agents · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, I.S.F. College of Pharmacy, GT Road, Moga, Punjab, India;

Department of Quality Assurance, I.S.F. College of Pharmacy, GT Road, Moga, Punjab, India;

Department of Pharmacology, I.S.F. College of Pharmacy, GT Road, Moga, Punjab, India;

Department of Pharmaceutics, Bhagyoday Tirth Pharmacy College, Sagar (MP), India

References (15)

Show source-provided references
1. Eskandari S · Int J Nanomedicine · 2011 · 6 · 363
2. 10.1016/j.ijpharm.2005.03.03110.1016/j.ijpharm.2005.03.031 ↗
3. 10.1177/107385840935438510.1177/1073858409354385 ↗
4. 10.1016/0003-2697(82)90118-X10.1016/0003-2697(82)90118-X ↗
5. 10.1078/0944-7113-0037610.1078/0944-7113-00376 ↗
6. 10.1016/S0928-0987(00)00087-710.1016/S0928-0987(00)00087-7 ↗
7. 10.1211/002235702253910.1211/0022357022539 ↗
8. 10.1016/S0169-409X(01)00172-710.1016/S0169-409X(01)00172-7 ↗
9. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
10. 10.1016/j.phymed.2010.04.00210.1016/j.phymed.2010.04.002 ↗
11. Müller RH · Adv Drug Deliv Rev · 2002 · 54 · S13110.1016/S0169-409X(02)00118-7 ↗
12. 10.1186/1756-6606-2-2010.1186/1756-6606-2-20 ↗
13. 10.1053/seiz.2000.045010.1053/seiz.2000.0450 ↗
14. 10.1016/0003-2697(69)90064-510.1016/0003-2697(69)90064-5 ↗
15. 10.1016/j.jconrel.2004.01.00510.1016/j.jconrel.2004.01.005 ↗